 |
| << Back | ||||||||||||||||||
| Dyax Corp. to Host Fourth Quarter and Year End 2009 Earnings Call and Webcast | ||||||||||||||||||
CAMBRIDGE, Mass., Feb 10, 2010 (BUSINESS WIRE) -- Dyax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and answer session, Wednesday, February 17, 2010, to discuss its financial results and company progress for the fourth quarter and year ended December 31, 2009.
A replay of the conference call will be available through March 17, 2010 and may be accessed by dialing 888-286-8010.International callers should dial 617-801-6888. The replay passcode for all callers is 15549425. The webcast will be archived on the Dyax website for an indefinite period of time. About Dyax Dyax is a fully integrated biopharmaceutical company focused on discovering, developing and commercializing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company utilizes its proprietary drug discovery technology, phage display, to identify antibody, small protein and peptide compounds for clinical development. Dyax also leverages this technology broadly with over 70 revenue generating licenses and collaborations for therapeutic discovery, as well as in non-core areas such as affinity separations, diagnostic imaging, and research reagents. Dyax is headquartered in Cambridge, Massachusetts. For online information about Dyax Corp., please visit http://www.dyax.com. SOURCE: Dyax Corp. Dyax Corp. |
|